Index test:prediction model

6 trials

Sponsors

Tibet Autonomous Region People's Hospital, Urology in Xiangya Hospital, Fudan University Shanghai Cancer Center, Fudan University Huashan Hospital, The First Hospital of Jilin University

Conditions

Bladder cancerGlioblastomaHospital-acquired pneumoniaRectal cancermultiple myelomavenous thromboembolism(VTE)

Phase 1

Development and validation of a clinical predictive model for radio-chemotherapy sensitivity and prognosis in glioblastoma based on expression profile genomics and clinical characteristics: an observational cohort study

Active, not recruitingChiCTR2000036047

Fudan University Huashan HospitalGlioblastoma

Start: 2021-01-01Updated: 2020-08-31

Unknown Phase

Development and validation of clinical prediction models for hospital-acquired pneumonia in Tibet autonomous region of China

Active, not recruitingChiCTR1900023192

Tibet Autonomous Region People's HospitalHospital-acquired pneumonia

Start: 2019-08-01Updated: 2019-05-20

The incidence, risk factors and the establishment of prediction model for VTE in urological inpatients

Active, not recruitingChiCTR1900027180

Urology in Xiangya Hospitalvenous thromboembolism(VTE)

Start: 2019-11-30Updated: 2019-11-04

Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning

Active, not recruitingChiCTR2000035917

Fudan University Shanghai Cancer CenterRectal cancer

Start: 2020-09-01Updated: 2020-08-24

The risk factors associated with early mortality in patients with newly diagnosed multiple myeloma: a prospective, multicenter, open-label and observational study

Active, not recruitingChiCTR2100050231

The First Hospital of Jilin Universitymultiple myeloma

Start: 2021-09-01Updated: 2022-04-25

Ultrasound-Based Diagnosis, Classification, and Prognostic Prediction of Bladder Cancer

Active, not recruitingChiCTR2600121952

Shanghai Tenth People's HospitalBladder cancer

Start: 2026-04-08Updated: 2026-04-14